Clinical Parkinsonism & Related Disorders Cellular and Molecular Neuroscience
Continuous subcutaneous foscarbidopa/foslevodopa infusion as a therapeutic option in spinocerebellar ataxia type 8 presenting with early-onset parkinsonism
The publisher did not provide an abstract — full text is available via the link below.